103
Participants
Start Date
November 28, 2018
Primary Completion Date
August 30, 2021
Study Completion Date
May 11, 2022
Xentuzumab
Intravenous infusion
Placebo
Intravenous infusion
Everolimus
Tablet
Exemestane
Tablet
Brussels - UNIV UZ Brussel, Jette
Brussels - UNIV Saint-Luc, Brussels
The Tweed Hospital, Tweed Heads
UZ Leuven, Leuven
Peninsula Haematology & Oncology, Frankston
Kortrijk - HOSP AZ Groeninge Kennedylaan, Kortrijk
Hematology Oncology Associates of Rockland, Nyack
"General Hospital of Athens Alexandra", Athens
INS Paoli-Calmettes, Marseille
Hospital Teresa Herrera, A Coruña
Metropolitan Hospital, Oncology Clinic, Neo Faliro, Athens
Hospital Arnau de Vilanova, Lleida
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Ramón y Cajal, Madrid
Hospital Clínico San Carlos, Madrid
Hospital Regional Universitario de Málaga, Málaga
University Cancer and Blood Center, Athens
INS Claudius Regaud IUCT-Oncopole, Toulouse
Florida Cancer Specialists, Fort Myers
Iov, Irccs, Padua
Tennessee Oncology, PLLC, Nashville
University Hospital of Larisa, Oncology Clinic, Larissa
Instituto Valenciano de Oncología, Valencia
Clínica Quirón de Valencia, Valencia
Hospital Clínico de Valencia, Valencia
Hematology Oncology of Indiana, Indianapolis
Euromedica Kyanous Stavros General Hospital, Thessaloniki
University of Minnesota, Minneapolis
HCA MidAmerica Division, Inc., Kansas City
HOP Lyon Sud, Pierre-Bénite
University General Hospital of Heraklion, Heraklion
HOP Victor Hugo, Le Mans
Southwestern Regional Medical Center, Tulsa
INS Curie, Paris
HOP Européen G. Pompidou, Paris
The Center for Cancer and Blood Disorders, Fort Worth
Vincentius-Diakonissen-Kliniken gAG, Karlsruhe
Istituto Nazionale IRCCS Tumori Fondazione Pascale, Napoli
INS Sainte Catherine, Avignon
Utah Cancer Specialists Cancer Center, Salt Lake City
Ironwood Cancer and Research Centers, Chandler
Cancer Treatment Centers of America at Western Regional Medical Center, Goodyear
Beverly Hills Cancer Center, Beverly Hills
Universitätsklinikum Erlangen, Erlangen
University of California San Francisco, San Francisco
Northwest Medical Specialties, PLLC, Tacoma
Yale Cancer Center, New Haven
CHU de Quebec-Universite Laval Research Centre, Québec
Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza, Roma
Fundação Champalimaud,, Lisbon
Hospital Beatriz Ângelo, Loures
Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia
Hospital Clínic de Barcelona, Barcelona
St Bartholomew's Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY